Therapeutic antibody research:
Discovery to functional assays

Live webinar

Recently, monoclonal antibody-based drugs have shown great potential as a treatment for several cancers. At Miltenyi Biotec, we offer a complete workflow for your antibody discovery research. From sample preparation, B cell separation and sorting, flow cytometry characterization and a standardized B cell culture protocol, we have tools, products and workflows to assist your research and help you find your lead candidate. In addition, we offer many solutions for efficient testing of your lead candidates in functional assays. Join our webinar, as we share insights into:

  • Our solutions for antibody discovery
  • Antibody functionality analysis
  • Functional assay highlights: ADCC and MLR

There will be time for questions and discussion after the 45 min presentation.


Sessions (choice of two dates)

September 1, 2020
Berlin, Germany (GMT+02:00)  − 7:00 PM CET
San Francisco, CA, USA (GMT-07:00) − 10:00 AM PST
New York, NY, USA (GMT-04:00)  − 1:00 PM EDT

Register here

September 3, 2020
Berlin, Germany (GMT+02:00)  − 10:00 AM CET
London, United Kingdom (GMT+01:00) − 9:00 AM GMT
Singapore, Singapore (GMT+08:00)  − 4:00 PM

Register here


About the presenter

Dr. Susanne Bethke 
Since 2018, Product Manager for B cell research, Miltenyi Biotec 
2014 – 2018, Ph.D. student, RWTH Aachen University „Generation of Plasmodium falciparum-specific human antibodies from Epstein-Barr virus-transformed B lymphocytes from semi-immune donors” at the Fraunhofer IME, Aachen 
2012 – 2014, Master studies in Biotechnology, FH Aachen University of Applied Sciences „Optimization of reporter plasmids for HPV-pseudovirion production in Nicotiana benthamiana plants” at the University of Cape Town, South Africa.

Susanne Bethke, Miltenyi Biotec